InsidersTradesSigma
Browse the complete record of transactions filed by Thackaberry Evan, SVP, Responsable du Développement Précoce. Director active across 1 companies, notably Vigil Neuroscience, Inc.. Cumulatively, 1 reports have been published. Total volume traded: €6k. The latest transaction was disclosed on 5 May 2022 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
1 of 1 declaration
Evan Thackaberry is the Senior Vice President and Head of Early Development at Vigil Neuroscience, Inc. He oversees research and development initiatives, focusing on innovation in the field of neuroscience. Thackaberry brings valuable expertise to guide the company's projects towards advanced therapeutic solutions.